1) Hp-related chronic gastritis
Hp相关性慢性胃炎
1.
Objective To observe the clinical efficacy and relapse rate in the treatment of Hp-related chronic gastritis with Banxia xie xin decoction and its impact on IL-8 and to explore its protective mechanism to the gastric mucosa.
目的观察半夏泻心汤加味辨证治疗Hp相关性慢性胃炎的临床疗效、复发率,以及其对IL-8变化的影响,探讨半夏泻心汤对胃黏膜的保护作用机制。
3) Hp-related chronic gastropathy
Hp相关慢性胃病
4) Hp-associated chronic gastritis
Hp相关性胃炎
1.
Objective:With triple therapy anti-Hp and Chinese medicine treating combined with triple therapy according to different syndromes of Hp-associated chronic gastritis,to reveal the triple therapy\'s influence of TCM Syndrome,as well as the effect of the combined treatment.
目的:应用抗幽门螺杆菌(Hp)三联疗法以及三联疗法联合中药辨证论治治疗Hp相关性胃炎,揭示三联疗法对中医证候的影响以及联合中药治疗的效果。
5) chronic gastritis
慢性胃炎
1.
Helicobacter pylori and relationship with degree of chronic gastritis;
幽门螺旋杆菌感染与不同程度慢性胃炎的关系
2.
Study on the relationship between TCM syndrome-type and the expression of gastrin and motilin in chronic gastritis;
慢性胃炎中医辨证分型与血清胃泌素和胃动素表达相关性研究
3.
Serum proteomics study of chronic gastritis with dampness syndrome in traditional Chinese medicine;
慢性胃炎中医湿证血清蛋白组学研究
6) gastritis
[英][ɡæ'straɪtɪs] [美][gæ'straɪtɪs]
慢性胃炎
1.
Significance of detection of serum anti-H pylori IgG and pepsinogen levels in patients with chronic gastritis or gastric cancer;
幽门螺杆菌抗体和血清胃蛋白酶原与慢性胃炎及胃癌的关系
2.
Conclusion Helicobacter pylori infection is the cause of chronic gastritis,especial.
结论 :Hp是慢性胃炎、尤其是慢性活动性胃炎、消化性溃疡的重要致病原因之一 ,还可能是胃癌的协同致癌
3.
[Objective]To observe the therapeutic effect and mechanism of smoothing the liver and regulating the stomach for treatment of Helicobacter pylorum(Hp)-related chronic gastritis.
[目的]观察疏肝和胃法治疗幽门螺杆菌相关性慢性胃炎的疗效及作用机制。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条